Research ArticleCancer

PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma

See allHide authors and affiliations

Science Translational Medicine  23 Sep 2020:
Vol. 12, Issue 562, eaay0152
DOI: 10.1126/scitranslmed.aay0152

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article